These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 2839326

  • 1. Lisinopril: a new angiotensin-converting enzyme inhibitor.
    Armayor GM, Lopez LM.
    Drug Intell Clin Pharm; 1988 May; 22(5):365-72. PubMed ID: 2839326
    [Abstract] [Full Text] [Related]

  • 2. Lisinopril: a new angiotensin-converting enzyme inhibitor.
    Chase SL, Sutton JD.
    Pharmacotherapy; 1989 May; 9(3):120-8; discussion 128-30. PubMed ID: 2547199
    [Abstract] [Full Text] [Related]

  • 3. Lisinopril: a nonsulfhydryl angiotensin-converting enzyme inhibitor.
    Noble TA, Murray KM.
    Clin Pharm; 1988 Sep; 7(9):659-69. PubMed ID: 2853660
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The clinical pharmacology of lisinopril.
    Case DE.
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():127-31. PubMed ID: 2550635
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Angiotensin-converting enzyme inhibitors: a comparative review.
    Raia JJ, Barone JA, Byerly WG, Lacy CR.
    DICP; 1990 May; 24(5):506-25. PubMed ID: 2188439
    [Abstract] [Full Text] [Related]

  • 9. Angiotensin converting enzyme inhibitors. Disparities in the mechanism of their antihypertensive effect.
    Garavaglia GE, Messerli FH, Nunez BD, Schmieder RE, Frohlich ED.
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):214S-216S. PubMed ID: 2843195
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The safety and tolerability of lisinopril in clinical trials.
    Rush JE, Merrill DD.
    J Cardiovasc Pharmacol; 1987 Jul; 9 Suppl 3():S99-107. PubMed ID: 2442561
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Onset of action of captopril, enalapril, enalaprilic acid and lisinopril in normal man.
    Semple PF, Cumming AM, Meredith PA, Morton JJ.
    Cardiovasc Drugs Ther; 1987 Jul; 1(1):45-50. PubMed ID: 2856460
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE).
    Cushman DW, Wang FL, Fung WC, Grover GJ, Harvey CM, Scalese RJ, Mitch SL, DeForrest JM.
    Br J Clin Pharmacol; 1989 Jul; 28 Suppl 2(Suppl 2):115S-130S; discussion 130S-131S. PubMed ID: 2557876
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.